These 2 biotech stocks could see double-digit upside over the next year.
Read MoreThese 3 stocks in the sector could deliver strong returns over the next twelve months.
Read MoreShares of Johnson & Johnson (JNJ) continued lower during Wednesday’s session due to a highly publicized trial against the multinational company in the state of Oklahoma. Investors have been skittish over the lead-up to the trial and its massive implications regarding the nationwide opioid crisis, scaring them into dragging the stock down to its lowest […]
Read MoreThe market’s rally from a low point on Christmas Eve last year has given a lot of investors reason to think that the worst of the correction before that, which tested bear market territory for all of the major market indices, is probably done. With seemingly positive news on the trade front working along with […]
Read MoreTechnology is evolving at a rapid pace, and we’re quickly approaching a future where everything from our daily commutes to going to the doctor will be completely revolutionized. For smart investors, identifying those businesses that are disrupting their industries and ushering in the future can lead to huge returns. Identifying these companies isn’t always easy, […]
Read MoreYou’ve heard the phrase, “be greedy when others are fearful.” Judging by the plunge in stocks this month, I think it’s safe to say investors are spooked. Market sell-offs like we’ve seen in the last few weeks tend to create opportunities, and there are two good opportunities in the healthcare sector that investors can now […]
Read More